{
"id":"mk19_b_gm_t31",
"number":31,
"bookId":"gm2",
"title":{
"__html":"Stress Dosing Strategies in Patients at Risk for Adrenal Insufficiency"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9f0c23",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 31. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t31"
}
]
},
"Stress Dosing Strategies in Patients at Risk for Adrenal Insufficiency"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b03a0",
"class":"col hd l",
"children":[
"Patient Risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dee5e2",
"class":"col hd l",
"children":[
"Patient Characteristics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fe4dbc",
"class":"col hd l",
"children":[
"Management"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"741fee",
"class":"cell txt l",
"children":[
"High risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3540c5",
"class":"cell txt l",
"children":[
"Established primary or secondary adrenal insufficiency"
]
},
" ",
{
"type":"p",
"hlId":"aefc86",
"class":"cell txt l",
"children":[
"Cushingoid features"
]
},
" ",
{
"type":"p",
"hlId":"20dc17",
"class":"cell txt l",
"children":[
"Current equivalent of >20 mg/d prednisone for >3 wk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c66632",
"class":"cell txt l",
"children":[
"Stress dosing"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ff10b",
"class":"cell txt l",
"children":[
"Moderate or possible risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"598a2e",
"class":"cell txt l",
"children":[
"Past use equivalent of >20 mg/d prednisone for >3 wk during past year"
]
},
" ",
{
"type":"p",
"hlId":"aa3ff2",
"class":"cell txt l",
"children":[
"Current or past equivalent of >5-20 mg/d prednisone for >3 wk during past year"
]
},
" ",
{
"type":"p",
"hlId":"dad1fe",
"class":"cell txt l",
"children":[
"Chronic high-dose inhaled or topical glucocorticoid therapy"
]
},
" ",
{
"type":"p",
"hlId":"2661e2",
"class":"cell txt l",
"children":[
"Recent intra-articular glucocorticoid therapy (â‰¥3 injectable glucocorticoid treatments within 3 mo before surgery)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"999abe",
"class":"cell txt l",
"children":[
"Stress dosing or preoperative adrenal axis testing may be indicated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5f59a",
"class":"cell txt l",
"children":[
"Low risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eca601",
"class":"cell txt l",
"children":[
"Equivalent of <5 mg/d of prednisone for any duration"
]
},
" ",
{
"type":"p",
"hlId":"7ea3c2",
"class":"cell txt l",
"children":[
"Any dose steroid for <3 wk"
]
},
" ",
{
"type":"p",
"hlId":"b25319",
"class":"cell txt l",
"children":[
"Low-dose inhaled or topical glucocorticoid therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f773b3",
"class":"cell txt l",
"children":[
"No stress dosing"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"Adapted from Liu MM, Reidy AB, Saatee S, et al. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017;127:166-72. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28452806",
"target":"_blank"
},
"children":[
"PMID: 28452806"
]
},
" doi:10.1097/ALN.0000000000001659 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020;75:654-63. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/32017012",
"target":"_blank"
},
"children":[
"PMID: 32017012"
]
},
" doi:10.1111/anae.14963"
]
]
}